UBS Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,925
| Closed | -$7K | – | 7755 |
|
|
2020
Q2 | $7K | Hold |
2,925
| – | – | ﹤0.01% | 6405 |
|
|
2020
Q1 | $4K | Buy |
2,925
+25
| +0.9% | +$34 | ﹤0.01% | 6526 |
|
|
2019
Q4 | $8K | Buy |
2,900
+336
| +13% | +$927 | ﹤0.01% | 6345 |
|
|
2019
Q3 | $14K | Sell |
2,564
-15,675
| -86% | -$85.6K | ﹤0.01% | 6014 |
|
|
2019
Q2 | $175K | Sell |
18,239
-676
| -4% | -$6.49K | ﹤0.01% | 4183 |
|
|
2019
Q1 | $507K | Sell |
18,915
-792
| -4% | -$21.2K | ﹤0.01% | 3360 |
|
|
2018
Q4 | $445K | Buy |
19,707
+5,489
| +39% | +$124K | ﹤0.01% | 3585 |
|
|
2018
Q3 | $785K | Buy |
14,218
+4,574
| +47% | +$253K | ﹤0.01% | 3337 |
|
|
2018
Q2 | $689K | Sell |
9,644
-8,751
| -48% | -$625K | ﹤0.01% | 3328 |
|
|
2018
Q1 | $1.13M | Buy |
+18,395
| New | +$1.13M | ﹤0.01% | 2939 |
|
|
2017
Q3 | – | Sell |
-33
| Closed | -$5K | – | 7000 |
|
|
2017
Q2 | $5K | Sell |
33
-830
| -96% | -$126K | ﹤0.01% | 6203 |
|
|
2017
Q1 | $159K | Buy |
863
+19
| +2% | +$3.5K | ﹤0.01% | 3945 |
|
|
2016
Q4 | $68K | Buy |
844
+534
| +172% | +$43K | ﹤0.01% | 4695 |
|
|
2016
Q3 | $24K | Buy |
310
+290
| +1,450% | +$22.5K | ﹤0.01% | 5277 |
|
|
2016
Q2 | $2K | Sell |
20
-505
| -96% | -$50.5K | ﹤0.01% | 6545 |
|
|
2016
Q1 | $48K | Sell |
525
-1,047
| -67% | -$95.7K | ﹤0.01% | 4750 |
|
|
2015
Q4 | $316K | Sell |
1,572
-449
| -22% | -$90.3K | ﹤0.01% | 3466 |
|
|
2015
Q3 | $302K | Buy |
2,021
+93
| +5% | +$13.9K | ﹤0.01% | 3428 |
|
|
2015
Q2 | $1.83M | Sell |
1,928
-85
| -4% | -$80.7K | ﹤0.01% | 2370 |
|
|
2015
Q1 | $1.48M | Buy |
2,013
+1,561
| +345% | +$1.14M | ﹤0.01% | 2518 |
|
|
2014
Q4 | $359K | Buy |
+452
| New | +$359K | ﹤0.01% | 3411 |
|